Trinseo PLC

TSEOQ Basic Materials Specialty Chemicals

Trinseo PLC’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, down 15.3% from fiscal 2024. In the quarter to June 2026, revenue grew 7.79%, EPS fell 10.9%, free cash flow fell 4,036.7% and total debt fell 76.3%, each against the same quarter a year earlier.

0.00 0.00 NaN
Market cap
$9.5M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
0.00%
F-score
1/9
Altman Z
0.20
Beneish M
−3.42
Dividend safety
0/100

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 8.69%

Capital & Financial Ratios $m

Market Cap 9.47
Revenue 2,975.90
Net Income (596.60)
Free Cash Flow (396.20)
Net Debt 410.10
Current Ratio 1.17
Debt/Equity (0.44) (negative: negative equity)
P/E ratio 0.00
Fwd P/E 0.00
P/S ratio 0.00
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth (17.81%) (below 0%: weak)
Next Y EPS Growth 25.25% (at or above 15%: strong)
Next Y revenue growth 6.02%
Next 5Y EPS Growth 11.33%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales against its own 10 years 1.70%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate 0.00
Annual Dividend Yield 0.00%
total individual payouts
2027 Powerpack
2026 Powerpack
2025 0.03
0.01
0.01
0.01
2024 0.04
0.01
0.01
0.01
0.01
2023 0.48
0.32
0.14
0.01
0.01
2022 1.28
0.32
0.32
0.32
0.32
2021 0.56
0.08
0.08
0.08
0.32
2020 1.60
0.40
0.40
0.40
0.40
2019 1.60
0.40
0.40
0.40
0.40
2018 1.52
0.36
0.36
0.40
0.40
2017 1.32
0.30
0.30
0.36
0.36
2016 0.60
0.30
0.30
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 259 210 147 181
Receivables 491 380 365 477
Inventory 405 347 316 391
Other 40 51 38 116
1,194 988 865 1,166
2023 2024 2025 Q'26
Payables 450 263 284 231
ST’ Debt 21 211 213 590
Other — — — —
673 721 715 999

Compound Annual Growth %

10y 5y 3y
Sales (2.85%) 1.62% (15.70%)
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value 0.00% 0.00% 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 725 845 — — —
’25 785 784 743 663 2,975
’24 904 920 868 822 3,513
’23 996 963 879 837 3,675
’22 1,387 1,426 1,178 975 4,966
’21 986 1,274 1,269 1,299 4,828
’20 854 534 679 678 2,745
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (233) (115) — — —
’25 (110) 7 (22) 23 (102)
’24 (66) (42) 9 85 (14)
’23 45 57 29 18 149
’22 (5) (83) 98 34 44
’21 51 (21) 208 215 453
’20 (6) 82 52 128 255
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (241) (124) — — —
’25 (119) (3) (38) 7 (153)
’24 (82) (48) (3) 56 (77)
’23 24 43 54 (41) 79
’22 (29) (115) 59 (20) (105)
’21 40 (40) 174 162 335
’20 (30) 68 43 109 189
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (3.20) (3.27) — — —
’25 (2.22) (2.95) (3.05) (6.98) (15.24)
’24 (2.14) (1.92) (2.47) (3.33) (9.86)
’23 (1.40) (9.93) (1.09) (7.53) (19.88)
’22 0.44 1.01 (3.41) (10.44) (11.99)
’21 1.81 3.82 2.36 3.14 11.12
’20 (0.94) (3.36) 2.75 1.71 0.20
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

3
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 21.92 57.70 42.10 27.36 14.16 44.20 17.54 5.48 1.94 0.45

Analyst estimates 2026–2028

Powerpack
High 62.30 75.20 85.35 52.34 52.69 76.49 59.73 30.54 8.58 5.99
People
People Employees 2,197 2,214 2,500 2,700 2,600 3,100 3,400 3,100 2,950 2,800
Revenue/emp, $m 1.69 2.01 1.85 1.25 1.06 1.56 1.46 1.19 1.19 1.06
Income, $m
Income, $m Revenue 3,717 4,448 4,623 3,374 2,745 4,828 4,966 3,675 3,513 2,975
Gross margin, % 15.93 14.39 11.44 8.90 11.70 14.48 5.48 3.87 7.56 5.58
EBT 405 411 364 100 105 351 (470) (633) (318) (503)
EBT margin, % 10.91 9.24 7.88 2.96 3.84 7.26 (9.46) (17.22) (9.05) (16.91)
Net income 318 328 293 87 8 440 (431) (701) (348) (546)
Depreciation 102 116 131 91 97 175 246 232 226 303
Per share, $
Per share, $ Revenue 79.93 101.55 108.01 83.72 71.66 124.74 138.31 104.12 99.52 83.10
Earnings 6.84 7.50 6.83 2.28 0.21 11.37 (11.99) (19.88) (9.86) (15.24)
Cash flow 8.68 8.93 8.56 8.00 6.67 11.70 1.21 4.21 (0.40) (2.86)
Capex (2.66) (3.37) (2.84) (2.08) (1.74) (3.04) (4.13) (1.97) (1.79) (1.42)
Free cash flow 6.02 5.57 5.73 5.92 4.93 8.66 (2.92) 2.24 (2.20) (4.28)
Book value 9.63 15.41 17.96 16.60 15.41 26.18 11.71 (7.59) (17.56) (30.66)
Shares, m 47 44 43 40 38 39 36 35 35 36
Valuation, ×
Valuation, × P/E 8.89 9.81 6.75 16.46 243.86 4.62 0.00 0.00 0.00 0.00
P/S 0.76 0.72 0.42 0.44 0.71 0.42 0.17 0.08 0.05 0.01
P/B 6.33 4.76 2.55 2.24 3.32 2.00 2.01 0.00 0.00 0.00
EV/Sales 0.95 0.89 0.58 0.66 0.93 0.78 0.59 0.64 0.68 0.81
EV/FCF 12.62 16.20 10.91 9.30 13.47 11.29 (28.17) 29.58 (30.73) (15.75)
Cash, $m
Cash, $m Operating cash flow 404 391 367 323 255 453 44 149 (14) (102)
Capex (124) (147) (121) (84) (67) (118) (148) (70) (63) (51)
Free cash flow 280 244 245 239 189 335 (105) 79 (77) (153)
Balance, $m
Balance, $m Working capital 891 1,020 1,094 964 984 1,064 701 522 267 150
Total debt 1,165 1,172 1,168 1,174 1,170 2,324 2,318 2,299 2,412 2,545
Net debt 700 739 716 718 582 1,751 2,106 2,039 2,202 2,399
Shareholders’ equity 448 675 769 669 590 1,013 420 (268) (620) (1,098)
Returns, %
Returns, % ROA 13.60 12.64 10.64 3.35 0.28 11.64 (10.17) (20.66) (12.29) (22.16)
ROIC 27.12 23.21 17.45 6.42 7.98 10.43 (9.00) (16.07) (1.82) (12.21)
ROE 76.08 58.49 40.53 12.80 1.25 54.88 (60.12) (920.95) 78.50 63.53
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Trinseo PLC vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
CITR CitroTech Inc. $68.2M — (loss-making) — −59.18% (below 0%: shrinking) n/m −30.95% (below 0%: shrinking) 3.21% (1,244.78%) Compare
LOOP Loop Industries, Inc. $18.0M — (loss-making) — (loss-making) −98.34% (below 0%: shrinking) n/m +60.46% (above 0%: growing) 0.00% (1,463.69%) Compare
TSEOQ Trinseo PLC $9.5M — (loss-making) — (loss-making) +7.79% (above 0%: growing) n/m −4,036.67% (below 0%: shrinking) 11.79% 0.01%
BON Bon Natural Life Limited $9.2M 0.9× 4.5× +20.95% (above 0%: growing) −14.29% (below 0%: shrinking) −260.38% (below 0%: shrinking) 33.34% 0.00% Compare
YMAT J-Star Holding Co., Ltd $6.1M — — — — — — — Compare
CRKN Crown Electrokinetics Corp. $5.8M — (loss-making) 0.3× +306.45% (above 0%: growing) n/m −362.52% (below 0%: shrinking) (36.69%) (357.14%) Compare
SNES Senestech, Inc. $3.8M — (loss-making) — (loss-making) +23.20% (above 0%: growing) n/m −42.77% (below 0%: shrinking) 73.64% (241.82%) Compare
BGLC BioNexus Gene Lab Corp. $3.6M — (loss-making) — −96.63% (below 0%: shrinking) n/m +44.32% (above 0%: growing) 17.06% (342.78%) Compare
CNEY CN Energy Group. Inc. $3.3M 2.3× 1.1× −99.90% (below 0%: shrinking) +33.33% (above 0%: growing) −113.57% (below 0%: shrinking) 3.28% 0.00% Compare
Median of peers $5.9M — 1.1× −59.18% — −42.77% 3.28% (342.78%)

All 60 Specialty Chemicals stocks →

Trinseo PLC (TSEOQ) key facts

  • Concern: Trinseo PLC’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, down 15.3% from fiscal 2024.
  • Trinseo PLC (TSEOQ) is a Specialty Chemicals company in the Basic Materials sector.
  • Return on equity was 63.5% and debt-to-equity -0.44.
  • Its Piotroski F-score is 1 out of 9 and its Altman Z-score is 0.20 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Trinseo PLC (TSEOQ) Latest News

stockrow.com/TSEOQ · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com